高级检索
当前位置: 首页 > 详情页

Oral drug delivery platforms for biomedical applications

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, China [2]Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA [3]Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of Denmark (DTU), 2800 Kgs. Lyngby, Denmark [4]The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou 510632, China [5]Orthopedics Department, Guangdong Provincial Hospital of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China [6]School of Material Science and Engineering, Zhengzhou University, Zhengzhou, Henan 450001, China
出处:
ISSN:

关键词: Oral drug gastrointestinal (GI) tract Delivery platforms Physiological barriers Biomedical applications

摘要:
Oral administration is perhaps the most commonly used and acceptable route for drug delivery to patients, mainly due to its non-invasiveness, simplicity, and versatility. Conventional delivery media such as tablets or capsule-based formulations, however, could result in low drug bioavailability and insufficient therapeutic efficiency, especially for delivering biologics (e.g., peptide, protein, antibody, nucleic acid). Therefore, with the advancement of material science and micro-/nano-fabrication techniques, various carriers have been developed to protect drugs and improve their absorption in the gastrointestinal (GI) tract. Herein, we first summarized various types of drug molecules being used for oral administration. Then we discussed the major physiological barriers (including various biochem-ical, mucosal diffusion, and cellular permeation barriers) that hinder drug transportation and absorption, as well as the main targeting regions in the GI tract. On this basis, we reviewed recently emerged oral drug delivery platforms and discussed their widely investigated biomedical applications. Finally, we present future perspectives for materials science-enabled oral drug delivery platforms, and potential challenges for clinical translation.

基金:
语种:
高被引:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 材料科学
小类 | 1 区 材料科学:综合
最新[2025]版:
大类 | 1 区 材料科学
小类 | 1 区 材料科学:综合
JCR分区:
出版当年[2021]版:
Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY
最新[2023]版:
Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, China [2]Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号